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Abstract We describe an enzyme-based electroanalysis
system for real-time analysis of a clinical microdialysis
sampling stream during surgery. Free flap tissue transfer is
used widely in reconstructive surgery after resection of
tumours or in other situations such as following major
trauma. However, there is a risk of flap failure, due to
thrombosis in the flap pedicle, leading to tissue ischaemia.
Conventional clinical assessment is particularly difficult in
such ‘buried’ flaps where access to the tissue is limited.
Rapid sampling microdialysis (rsMD) is an enzyme-based
electrochemical detection method, which is particularly
suited to monitoring metabolism. This online flow injection
system analyses a dialysate flow stream from an implanted
microdialysis probe every 30 s for levels of glucose and
lactate. Here, we report its first use in the monitoring of free
flap reconstructive surgery, from flap detachment to re-
vascularisation and overnight in the intensive care unit.
The on-set of ischaemia by both arterial clamping and failure
of venous drainage was seen as an increase in lactate and
decrease in glucose levels. Glucose levels returned to normal
within 10min of successful arterial anastomosis, whilst lactate
took longer to clear. The use of the lactate/glucose ratio
provides a clear predictor of ischaemia on-set and subsequent
recovery, as it is insensitive to changes in blood flow such as
those caused by topical vasodilators, like papaverine. The use
of storage tubing to preserve the time course of dialysate,
when technical difficulties arise, until offline analysis can
occur, is also shown. The potential use of rsMD in free flap
surgery and tissue monitoring is highly promising.
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Introduction
Despite the increasing sophistication of modern surgical pro-
cedures, complications such as the development of ischaemia
due to a disrupted blood supply are relatively common and
difficult to detect. If such complications are detected, further
emergency surgical intervention may be required. If it goes
unnoticed, there is a high associated morbidity.
Microdialysis is a minimally invasive technique ideal for
the clinical monitoring of tissue, particularly in difficult to
observe areas. In this technique, a thin double-lumen cath-
eter with a semi-permeable membrane at its end is inserted
into the tissue. A physiological perfusion fluid is pumped
through the catheter using a small pump, and small mole-
cules such as glucose and lactate, pass via the membrane
into the fluid creating a dialysate stream. In conventional
microdialysis, this dialysate is collected in microvials. One
of the main problems with this technique is that, with a
perfusion rate of 0.3–2 μL/min, the time taken to collect a
sufficient volume for assay in a bedside analyser can take
30 min to an hour. The sample then needs to be introduced
into a bedside analyser by hand (requiring attention from
busy clinical staff) and the analysis itself usually takes
another few minutes before concentrations of glucose, lac-
tate and other metabolites are displayed. This loses dynamic
information preventing real-time detection of adverse
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events. An exciting new method for real-time analysis of
tissue metabolites has been developed. An online flow in-
jection system, known as rapid sampling microdialysis
(rsMD), is used to monitor tissue levels of glucose and
lactate at the bedside [1]. rsMD has also successfully been
used to monitor metabolites in animal models of ischaemia
[2], during human gastrointestinal [3] and human brain
surgery [4], as well as monitoring brain injury patients on
the intensive care ward [5].
Free tissue transfer is the process of harvesting soft tissue
(such as skin and muscle and sometimes with associated
bone) together with its blood supply. Healthy tissue is pre-
pared at the donor site and the blood supply is clamped and
cut, thus creating a free flap. Microsurgery is then used to
re-establish the blood supply at the recipient site. After re-
vascularisation, there is a risk of thrombosis in the artery or
vein leading to flap ischaemia and failure. Hence, early
recognition of flap compromise is essential for successful
reconstruction. The majority of free flaps that fail do so
within the first 24 h [6] and current clinical assessment
includes flap colour, temperature and turgidity. Recently,
modalities including Doppler flowmetry and microdialysis
for measuring metabolism have gained popularity in pre-
dicting flap compromise [7, 8]. However, some question
whether these techniques are superior to clinical assessment
alone [9]. Conventional microdialysis has already been used
to detect tissue ischaemia during free flap surgery [10], in
the oral cavity [11] and in buried flaps [12].
Here, we report for the first time the use of real-time
microdialysis to monitor free flap surgery and the relocated
tissue in the post-operative period.
Materials and methods
Clinical analysis system
The dialysate was analysed using rsMD by directly connect-
ing a clinical microdialysis probe (CMA70, MDialysis, Solna
Sweden) to an enzyme-based electrochemical detectionmethod
via low-volume fluorinated ethylene propylene (FEP) connec-
tion tubing (0.12μL/cm, Thames-Restek, Bucks). An overview
of the setup is shown in Fig. 1. The analysis equipment is
assembled on a clinically approved isolation trolley (CTLMed-
ical). This is critical as it provides (a) the necessary patient
isolation, (b) as importantly acceptability by clinical staff within
the operating theatre environment and (c) a workspace for the
monitoring team. Patient electrical isolation occurs at three
levels: the very high impedance of the saline-filled FEP tubing,
electrically isolated power supplies for the potentiostats and
overall isolation transformer for the clinical trolley.
The analysis system consists of a custom-made six-port
injection valve with two 200 nL internal sample loops made
by Valco Instruments, Switzerland, coupled to a precision
HPLC pump (Rheos 2200, Flux Switzerland). Every 30 s, the
valve injects microdialysate samples into a mediator flow
stream (1.5 mM ferrocene monocarboxylate, 100 mM sodium
citrate, 150 mM sodium chloride, 1 mM EDTA, Kathon (Rohn
and Haas), pH 7), which passes through either a glucose or a
lactate enzyme reactor. The reactors house nitrocellulose-based
nanoporous membranes (Millipore) with high enzyme loading
for efficient sequential transfer of the electrons from the sub-
strate via hydrogen peroxide to horseradish peroxidase (HRP)
which was regenerated by a synthetic mediator, ferrocene
monocarboxylate (Sigma-Aldrich) [13]. A downstream elec-
trode (3 mm, radial flow glassy carbon disc) operating at 0 V
compared to the Ag|AgCl|Cl− (150 mM) direct reading refer-
ence electrode reduces the ferrocene (III) species produced by
HRP back to ferrocene (II) to give a current peak; this is shown
schematically in Fig. 1b. The use of a reducing potential
prevents interference from electroactive species that may be
present in the dialysate. Our careful choice of buffer chloride
concentration has two benefits: Firstly, our in-house low-noise
potentiostats are able to operate using an internally set potential
of 0 V, dramatically reducing noise by a factor of 10 [14].
Secondly, it matches the chloride concentration in the micro-
dialysis streamminimising injection artefacts. The potentiostats
are connected to a 16/35 Powerlab (ADInstruments) and the
data are recorded using LabChart software (ADInstruments)
which also timestamps key events during the surgery with the
raw data files and allows us to record audio/video files time-
locked to the data for unambiguous identification of event
timing. The current peak from each sample injection is dis-
played on a computer screen in real time, with current inverted
for convenience (Fig. 1c). This allows the monitoring team to
give the surgical team a commentary on glucose and lactate
levels during the surgical procedure.
Data analysis
The amplitude of the current peak is related to the concen-
tration of substrate in the dialysate by calibrations. The
system is calibrated from 0.25 to 5 mM (four steps each
with five replicates) before surgery, after surgery and after
monitoring in the ICU by injection of known standards
directly into the valve using a glass Hamilton syringe
(Fig. 1c, e). This allows accurate conversion of the current
signal into concentration. If required, one-off injections of a
standard can occur during monitoring to track the assay
stability. Typically, the analysis method has 5-day stability
and a detection limit of 25 μM [15]. The raw data containing
injection peaks are processed using MatLab (MathWorks).
Purpose-written published algorithms are used to remove
common noise artefacts such as spikes, ripples and baseline
drift, typically improving the signal-to-noise ratio by 250 %
[15]. The peaks are then detected and compared to the
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relevant calibration function to give values for microdialy-
sate concentration.
Storage tubing
As each surgery is a unique event, the data collected are of
high value; hence, an alternative method of data collection
has been developed for circumstances when online analysis
cannot be achieved. With use of 0.4 mm ID Portex tubing,
63 min of dialysate can be collected per 1 m length at
2 μL/min, with retention of temporal information. This
allows sections of dialysate to be analysed at a later date.
Figure 2 shows the raw data of dialysate collected as the
microdialysis probe was removed from the tissue. The dial-
ysate had been stored at 4 °C for 10 days before analysis, yet
we can see stable levels, which fade to zero in both the
glucose and lactate graphs at the correct time probe removal.
Sterility in surgery
One of the main problems was to bridge the sterility barrier
from the patient to the analysis system during the often
lengthy periods of surgery. The microdialysis probe and
perfusion solution are both sterile, however, our analysis
system and connection tubing are not. To overcome this,
we use a sterilised tubular polyethylene camera drape. This
allows the non-sterile equipment (CMA microdialysis pump
and connection tubing) to be placed inside the drape and
close to the patient without the worry of contamination.
Surgical protocol
Ablative surgery, to remove the tumour, was completed and
the flap was raised concurrently. Prior to division of the
blood vessels (creating a free flap), a CMA70 microdialysis
probe (MDialysis, Solna, Sweden, 10 mm membrane,
20 kDa cut-off) was inserted and secured subcutaneously
into the flap using a suture at the hard plastic union (avoid-
ing the soft concentric tubes); a photograph can be seen in
Fig. 1a. The probe was perfused with sterile T1 solution
(MDialysis) at 2 μL/min. Prior to detachment of the flap,
baseline dialysate levels of glucose and lactate were
recorded. A vasodilator, papaverine, was then applied topi-
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Fig. 1 The microdialysis probe is inserted into the tissue flap subcu-
taneously and sutured into place, shown in the photograph in (a) before
the flap has been detached from the blood vessels. The dialysate is
introduced to the rsMD injection valve via low-volume FEP connection
tubing (blue dotted line). The reaction is mediated by ferrocene mono-
carboxylate, which is perfused at 200 μL/min using an HPLC pump. The
enzyme is loaded onto membranes placed before a glassy carbon elec-
trode which is held at 0 V (b). The current is recorded as peaks, where
amplitude is related to concentration as shown in the calibration curve in
(c). Raw data of a successful arterial anastomosis (indicated by the dotted
grey line) are shown in (d). A time line indicating the calibration protocol
throughout monitoring is shown in (e)
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tissue. The microdialysis probe remained connected with
online analysis as the flap was detached and moved to the
donor site. The free flap artery was anastomosed to the facial
artery first, followed by the vein and then reconstruction of
the recipient site. The patients were transferred to the ICU
and kept sedated and ventilated overnight. rsMD was con-
tinued for a 10-h period before the microdialysis probe was
removed. The glucose and lactate levels were recorded, with
routine flap observations (colour, temperature and turgidity)
carried out in addition.
Results and discussion
Of the five cases monitored to date, two cases will be
described in detail, highlighting key events during surgery.
Case study 1
The glucose and lactate levels throughout surgery of a 39-
year-old male presenting a carcinoma of the tongue are
shown in Fig. 3. Ten minutes after probe insertion, baseline
dialysate levels stabilised to 1.26±0.03 mM glucose and
0.57±0.02 mM lactate (n=10). These values are lower than
the better-perfused bowel (2.77±0.57 mM glucose, 0.77±
0.17 mM lactate) [3] but much higher than the brain (glu-
cose typically ranges from 0.3 to 0.7 mM and lactate base-
line levels range from 0.4 to 0.7 mM) [5] where blood flow
is tightly regulated.
Before detachment of the flap from the forearm, a vaso-
dilator, papaverine, was applied to the blood vessels. After
application, the levels of both glucose and lactate increased.
Most probably, this is due to an increase in the blood
Fig. 2 Raw data from dialysate
collected during surgery into a
collection tubing. The probe
was removed from the tissue
during collection. The dialysate
was stored for 10 days at 4 °C
and analysed using rsMD. The
data shown have had no noise
removal algorithms applied.
The top graph shows glucose
data and the bottom graph
shows lactate data
Fig. 3 Analysis of data
collected during free flap
surgery. The top graph (blue)
shows the lactate/glucose ratio.
The bottom graph shows
glucose (red) and lactate
(green) levels throughout the
reconstructive surgery. Time
zero is the time from stable
baseline (10 min after probe
insertion). The dotted lines
indicate key events logged as
communicated by the surgeons
to the monitoring team in
real time
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volume to the tissue that the probe is sampling from. As the
changes of glucose and lactate are in the same direction,
they could be due to a transient change in the efficiency of
microdialysis probe recovery [1]. To control for this, and
hence simplify the analytical measurement, a ratio of the
two metabolites has been used. The lactate/glucose ratio
does not change during the application of papaverine, indi-
cating the same percentage increase in both lactate and
glucose reflecting a change in probe recovery.
When the flap was detached, by division of the blood
vessels (just after 1 h in Fig. 3), the dialysate glucose
concentration fell and the lactate concentration increased.
This change in levels in opposite directions is a reliable
microdialysis signature [1]. This is reflected in the near
exponential rise in the lactate/glucose ratio seen after the
artery has been clamped and severed.
Upon successful arterial anastomosis (reconnection of the
arterial supply to the free flap in its transferred position in
the oral cavity, at 1.8 h in Fig. 3), the arterial clamp is
released and a check is made in any leak at the anastomosis
site and that blood visibly flows into the flap and flows out
of the veins. Once blood flow is reconfirmed, all the clamps
are re-applied. We observed a rapid rise in dialysate glucose
concentration to 1.75±0.14 mM (n=10), within 11 min. The
raw data for this event are shown in Fig. 1d. The lactate
level was maintained for 7 min before returning to an
elevated baseline (0.78±0.01 mM, n=10). This may repre-
sent the fact that lactate is neither being utilised nor cleared
efficiently by local blood flow. Although levels return to
near baseline, signs of a second ischaemia developed within
30 min, albeit the concentration changes of glucose and
lactate were not as large. This is most clearly seen in the
lactate/glucose ratio.
Once the venous anastomosis has been completed (at
2.75 h in Fig. 3), all of the clamps are removed and the second
ischaemia is relieved, seen as a fall in lactate/glucose ratio, a
product of the sharp rise in glucose and delayed fall in lactate
dialysate levels. Therefore, we conclude that a ratiometric
approach to monitoring tissue ischaemia gives a strong indi-
cator of flap health compared to the evaluation of individual
metabolites. Furthermore, the excellent signal to noise of the
lactate/glucose ratio makes it a robust predictor of the on-set of
ischaemia that is suitable for real-time clinical use.
The patient was transferred to ICU where monitoring was
continued (Fig. 4). The levels of both glucose and lactate are
higher at the beginning of this monitoring period than at the
end of surgery. However, there is a clear trend of falling
lactate concentration and rising glucose levels. Over the
10 h that the flap was monitored in the ICU, the lactate/glu-
cose ratio was seen to steadily fall to the level it was before
the flap was raised from the forearm. The tissue reconstruc-
tion was successful by normal clinical indicators.
Case study 2
Figure 5 shows two extracts of glucose and lactate levels and
the ratio of a more complicated surgery of a 47-year-old male,
where muscle and bone from the leg were used to reconstruct
the jaw. Baseline levels of glucose and lactate were 2.05±0.36
(n=10) and 5.55±0.60 mM (n=10), respectively.
As with case study 1, after detachment of the flap, the tissue
concentration of glucose fell and the lactate/glucose ratio in-
creased indicating tissue ischaemia. Upon the first attempt at
anastomosis (both arterial and venous), the changes in the level
of glucose were much smaller than that of case study 1. The
levels of glucose and lactate remain on their downward and
upward trends, respectively, which is more clearly shown by a
continuation of an upward trend in the lactate/glucose ratio as
shown in Fig. 5a. This demonstrates the unsuccessful reperfu-
sion of blood through the free flap tissue. Upon investigation,
Fig. 4 Analysis of data
collected during ICU
monitoring. The top graph
shows the lactate/glucose ratio.
The bottom graph shows the
glucose (red) and lactate
(green) levels
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large blood clots were found at all anastomosis sites and later an
undetected rare blood disorder was confirmed.
The patient was then thrombolysed and the anastomosis
was re-attempted with success (shown in Fig. 5b). Here, the
glucose concentration dramatically increases from 0.32±
0.02 mM (n=10) to 4.85±0.48 mM (n=10) whilst the lactate
levels are slower to change. The successful reperfusion is
shown most clearly in the lactate/glucose ratio, which falls
dramatically from 17.19±0.44 (n=10) to 0.77±0.07 (n=10).
These data highlight the reliability of the monitoring system
for online and real-time detection of successful reperfusion
during surgery.
Once the patient was transferred to ICU, monitoring con-
tinued for 10 h. During this time, the level of glucose dropped
a bFig. 5 Two extracts from onesurgery showing (a) a failed
anastomosis and (b) a
successful anastomosis in terms
of lactate (green), glucose (red)
and the lactate/glucose ratio
(blue). Time zero is the time of
connection, conveyed by the
surgeons and recorded in
real time
a b cFig. 6 Histograms highlightingkey moments during rsMD
monitoring: (i) Baseline. (ii)
Flap detached. (iii) Flap
reattached. (iv) Levels at the
end of monitoring in ICU. A
Mann–Whitney–Wilcoxon test
was used to assess the changes
from baseline within each case
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from 4.41±0.08 mM (n=10) to 0.21±0.002 mM (n=10) and
the lactate/glucose ratio gradually increased from 1.10±0.02
(n=10) to 11.44±0.26 (n=10). Some time after microdialysis
monitoring was ceased, the flap failed, and at this later date,
further surgical intervention was required.
An overview of the dialysate levels of glucose and lactate
and the lactate/glucose ratio throughout these two patient
cases is shown in Fig. 6. A Mann–Whitney–Wilcoxon test
has tested for changes from the baseline within each case
(before the blood supply to the tissue had been cut) to three
clear points throughout the monitoring period, detachment of
the flap, full successful reconnection and the levels in ICU. All
changes show high significance indicating that monitoring
these key metabolic markers during free flap and reconstruc-
tive surgery has potential to evaluate the ‘health’ of the tissue
in real time. In both cases when the blood supply to the flap is
disconnected, the lactate/glucose ratio clearly increases. This
change is much harder to see from assessment of the glucose
and lactate data taken individually, although the levels of
glucose in the dialysate seem to be more responsive to, and
therefore more indicative of, tissue perfusion. When the tissue
has successfully been reconnected, again it is clear to see the
trends in both the lactate/glucose ratio and the level of dialy-
sate glucose reverse. In ICU, case 1 shows no complications,
with a higher level of dialysate glucose than the baseline and a
low lactate/glucose ratio. Whilst at the end of monitoring of
case 1, the flap was successful, and few days after micro-
dialysis monitoring ceased, the flap failed and further surgery
was required. This may explain the low dialysate glucose
levels and high lactate/glucose ratio seen.
Conclusion
We have successfully monitored the metabolic health of a free
flap, in real time, during and after free flap reconstructive
surgery, using rsMD. The potential value of these measure-
ments to reconstructive surgeons is exciting. rsMD offers a
considerable advantage over offline microdialysis because of
the inherent time delays that necessarily occur with the latter
technique. Using a lactate/glucose ratiometric approach is a
strong indicator of tissue health, as it is insensitive to flow and
recovery artefacts, leaving a clear and easily interpretable
predictor of ischaemia. In the exemplar cases, we can clearly
see ischaemia on-set following both arterial occlusion and
failure of venous drainage, the two most common causes of
flap failure. Unsuccessful anastomosis during surgery is
shown to be easily distinguishable to that of successful anas-
tomosis and tissue reperfusion. We have also demonstrated, in
real time, the effects of topically applied drugs (papaverine).
The research applications for further study of the real-time
metabolic changes that occur during free flap harvest, detach-
ment and re-vascularisation are many.
From the patients monitored to date, there is considerable
variability in the tissue levels and responses between
patients due to many co-variates such as age, sex, underly-
ing health issues, etc. as well as effectiveness of the micro-
dialysis sampling. Full statistical analysis will require a
larger cohort. From these preliminary data, the relative
changes in glucose, lactate and particularly the lactate/glu-
cose ratio within a patient data set clearly show dynamic
trends that reflect tissue health.
Future work includes monitoring a larger cohort of
patients for full clinical analysis. On-going optimisation
using new technologies, such as a microfluidic manifold
with incorporated electrochemical sensors [16], will only
improve the system and the quality of the results further
still.
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